Michael Pellini

Director/Miembro de la Junta en

Coriell Institute for Medical Research

60 años

76 relaciones

Health Services

Commercial Services

Health Technology

Perfil

Michael J.
Pellini currently works at American Cancer Society, Inc., as Director-at-Large from 2023, Mission Hospital Foundation, as Director, Personalized Medicine Coalition, as Director, Octave Bioscience, Inc., as Director from 2018, Vineti, Inc., as Director, Twinstrand Biosciences, Inc., as Director, Cradle Genomics, Inc., as Director, Octave Health Group, Inc., as Director, Nusano, Inc., as Director, Go2 Foundation For Lung Cancer, as Director, Exai Bio, Inc., as Director, Thomas Jefferson University, as Member-President Leadership Council, Boston College, as Member-Technology Council, Coriell Institute for Medical Research, as Trustee, and Section 32 LLC, as Managing Partner from 2017.
Dr. Pellini also formerly worked at Genomics Collaborative, Inc., as President & Chief Executive Officer from 1999 to 2004, Foundation Medicine, Inc., as Chairman from 2017 to 2018, Adaptive Biotechnologies Corp., as Independent Director from 2018 to 2025, Acelerate, Inc., as Director, Cira Discovery Sciences, Inc., as Director, Tango Therapeutics Sub, Inc., as Director from 2018 to 2021, Sema4 OpCo, Inc., as Director from 2019 to 2021, Thrive Earlier Detection Corp., as Director, GeneDx Holdings Corp., as Independent Director from 2021 to 2023, Singular Genomics Systems, Inc., as Lead Independent Director from 2017 to 2025, Safeguard Scientifics, Inc., as Vice President-Life Sciences Group from 2007 to 2008, Clarient, Inc., as President & Chief Operating Officer from 2009 to 2011, Ben Franklin Technology Partners, as Investment Committee Member, and PLUS Diagnostics, Inc., as Chief Operating Officer & Executive Vice President from 2005 to 2006.
Dr. Pellini received his Masters Business Admin degree in 1992 from Drexel University, undergraduate degree in 1987 from Boston College, and doctorate degree from Sidney Kimmel Medical College.

Cargos activos de Michael Pellini

Empresas	Cargo	Inicio
Coriell Institute for Medical Research Coriell Institute for Medical Research Miscellaneous Commercial ServicesCommercial Services Operates as a human genome research organization	Director/Miembro de la Junta	-
Boston College Boston College Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
Personalized Medicine Coalition Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services Engages in promoting the understanding and adoption of personalized medicine concepts, services and products	Director/Miembro de la Junta	-
Section 32 LLC Section 32 LLC Investment ManagersFinance Section 32 invests in companies located in the United States. The firm focuses on companies operating in the field of technology sector. It provides financing for early stage capital requirements.	Inversor de Capital Privado	01/12/2017
Octave Bioscience, Inc. Octave Bioscience, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services	Director/Miembro de la Junta	12/07/2018
Vineti, Inc. Vineti, Inc. Medical/Nursing ServicesHealth Services Develops software for scaling and digital solutions for cell and gene therapies	Director/Miembro de la Junta	-
Mission Hospital Foundation	Director/Miembro de la Junta	-
Cradle Genomics, Inc. Cradle Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing life sciences	Director/Miembro de la Junta	-
Nusano, Inc. Nusano, Inc. Medical SpecialtiesHealth Technology Manufactures medical radioisotope products	Director/Miembro de la Junta	-
░░░ ░░░░░░░░░░ ░░░ ░░░░ ░░░░░░	░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░	-

Todos los cargos activos de Michael Pellini

Antiguos cargos conocidos de Michael Pellini.

Empresas	Cargo	Fin
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░	░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░░░░ ░░░░░	░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░	░░░░░░░░░░
░░░░░ ░░░░░ ░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░	░░░░░░░░░░

Ver el detalle de la experiencia de Michael Pellini.

Formación de Michael Pellini.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Michael Pellini.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	30
Safeguard Scientifics, Inc. Safeguard Scientifics, Inc. Investment ManagersFinance Invests in technology companies	Finance
Clarient, Inc. Clarient, Inc. Medical/Nursing ServicesHealth Services Provides cancer diagnostic testing services	Health Services
Thomas Jefferson University Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Acelerate, Inc. Acelerate, Inc. BiotechnologyHealth Technology Provides systems cell biology solutions	Health Technology
Genomics Collaborative, Inc. Genomics Collaborative, Inc. Medical SpecialtiesHealth Technology Provides clinical samples and the application of human genetics to target validation for drug discovery	Health Technology
Boston College Boston College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
American Cancer Society, Inc. American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research	Commercial Services
Ben Franklin Technology Partners /Ventures/ Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Tech Partners invests in companies located in the US. The firm focuses on IT, life sciences and physical sciences. It participates in seed and early-stage capital requirements.	Finance
PLUS Diagnostics, Inc. PLUS Diagnostics, Inc. Medical/Nursing ServicesHealth Services Provides anatomic pathology services	Health Services
Mission Hospital Foundation
Cira Discovery Sciences, Inc. Cira Discovery Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops pattern discovery algorithms for genomic and other life sciences studies	Commercial Services
Coriell Institute for Medical Research Coriell Institute for Medical Research Miscellaneous Commercial ServicesCommercial Services Operates as a human genome research organization	Commercial Services
Personalized Medicine Coalition Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services Engages in promoting the understanding and adoption of personalized medicine concepts, services and products	Commercial Services
Foundation Medicine, Inc. Foundation Medicine, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic solutions for cancer care	Health Services
Lebow College of Business Lebow College of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Adaptive Biotechnologies Corp. Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine	Health Technology
Octave Bioscience, Inc. Octave Bioscience, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services	Health Services
Vineti, Inc. Vineti, Inc. Medical/Nursing ServicesHealth Services Develops software for scaling and digital solutions for cell and gene therapies	Health Services
Twinstrand Biosciences, Inc. Twinstrand Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops genomic technology and duplex sequencing technology to applications in clinical medicine & life sciences	Commercial Services
Tango Therapeutics Sub, Inc. Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops transformational new drugs for cancer patients	Health Technology
Section 32 LLC Section 32 LLC Investment ManagersFinance Section 32 invests in companies located in the United States. The firm focuses on companies operating in the field of technology sector. It provides financing for early stage capital requirements.	Finance
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Develops scalable spatial multiomics technology for precision diagnostics and personalized medicine	Commercial Services
Mount Sinai Genomics, Inc. Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases	Health Services
Thrive Earlier Detection Corp. Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Develops liquid biopsy test that is designed to detect cancers at early stages	Health Technology
Cradle Genomics, Inc. Cradle Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing life sciences	Commercial Services
Octave Health Group, Inc. Octave Health Group, Inc. Medical/Nursing ServicesHealth Services Provides online therapy services	Health Services
GeneDx Holdings Corp. GeneDx Holdings Corp. Medical/Nursing ServicesHealth Services Provides diagnostic genetic testing services	Health Services
Nusano, Inc. Nusano, Inc. Medical SpecialtiesHealth Technology Manufactures medical radioisotope products	Health Technology
Go2 Foundation For Lung Cancer Go2 Foundation For Lung Cancer Go2 Foundation For Lung Cancer is a national nonprofit organization focused on confronting lung cancer through education, support, advocacy, and research. The private company is based in Washington, DC. The foundation provides resources on lung cancer types, risk factors, symptoms, diagnosis, staging, and treatment options such as surgery, chemotherapy, radiation, targeted therapy, immunotherapy, biomarker testing, and clinical trials. It promotes early detection through lung cancer screening with low-dose CT scans and supports a national network of centers of excellence for lung cancer care. The organization offers personalized assistance via a free helpline, peer support programs, online social groups, coping skills workshops, and educational events. Go2 Foundation advances lung cancer research through initiatives like the lung cancer registry and partnerships with research institutes, and advocates for increased research funding, improved healthcare access, and reduced stigma. Community engagement is encouraged through fundraising, advocacy campaigns, awareness events, and sharing personal stories. Educational materials are provided in multiple formats and languages. The CEO of the company is Laurie Fenton Ambrose.
Exai Bio, Inc. Exai Bio, Inc. Packaged SoftwareTechnology Services Develops a ribonucleic acid-based liquid biopsy platform for early cancer detection	Technology Services